Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen F Betz

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|January 28, 2003
Function first: a powerful approach to post-genomic drug discoveryStephen F Betz, Susan M Baxter, Jacquelyn S Fetrow
Biochemistry|January 5, 2005
The crystal structure of a quercetin 2,3-dioxygenase from Bacillus subtilis suggests modulation of enzyme activity by a change in the metal ion at the active site(s)B Gopal, Lalima L Madan, Stephen F Betz, et al.
Journal of Medicinal Chemistry|January 20, 2006
Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptorStephen F Betz, Greg J Reinhart, Francisco M Lio, et al.
Frontiers in Endocrinology|October 14, 2022
Somatostatin receptors in congenital hyperinsulinism: Biology to bedsideMirjam E van Albada, Klaus Mohnike, Mark J Dunne, et al.
The Journal of Biological Chemistry|May 13, 2023
A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinismChristine A Juliana, Jinghua Chai, Pablo Arroyo, et al.
Pituitary|January 9, 2022
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteersAjay Madan, Stacy Markison, Stephen F Betz, et al.
Biochemical Pharmacology|June 6, 2006
Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptorSam R J Hoare, Brock T Brown, Mark A Santos, et al.
Journal of Biomolecular Screening|November 6, 2003
A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screeningPhilip J Hajduk, Stephen F Betz, Jamey Mack, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonistJian Zhao, Zhiyong Chen, Ana Karin Kusnetzow, et al.
Journal of Medicinal Chemistry|October 13, 2006
Determination of the binding mode of thienopyrimidinedione antagonists to the human gonadotropin releasing hormone receptor using structure-activity relationships, site-directed mutagenesis, and homology modelingStephen F Betz, Francisco M Lio, Yinghong Gao, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|January 28, 2003
Function first: a powerful approach to post-genomic drug discoveryStephen F Betz, Susan M Baxter, Jacquelyn S Fetrow
Biochemistry|January 5, 2005
The crystal structure of a quercetin 2,3-dioxygenase from Bacillus subtilis suggests modulation of enzyme activity by a change in the metal ion at the active site(s)B Gopal, Lalima L Madan, Stephen F Betz, et al.
Journal of Medicinal Chemistry|January 20, 2006
Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptorStephen F Betz, Greg J Reinhart, Francisco M Lio, et al.
Frontiers in Endocrinology|October 14, 2022
Somatostatin receptors in congenital hyperinsulinism: Biology to bedsideMirjam E van Albada, Klaus Mohnike, Mark J Dunne, et al.
The Journal of Biological Chemistry|May 13, 2023
A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinismChristine A Juliana, Jinghua Chai, Pablo Arroyo, et al.
Pituitary|January 9, 2022
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteersAjay Madan, Stacy Markison, Stephen F Betz, et al.
Biochemical Pharmacology|June 6, 2006
Single amino acid residue determinants of non-peptide antagonist binding to the corticotropin-releasing factor1 (CRF1) receptorSam R J Hoare, Brock T Brown, Mark A Santos, et al.
Journal of Biomolecular Screening|November 6, 2003
A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screeningPhilip J Hajduk, Stephen F Betz, Jamey Mack, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonistJian Zhao, Zhiyong Chen, Ana Karin Kusnetzow, et al.
Journal of Medicinal Chemistry|October 13, 2006
Determination of the binding mode of thienopyrimidinedione antagonists to the human gonadotropin releasing hormone receptor using structure-activity relationships, site-directed mutagenesis, and homology modelingStephen F Betz, Francisco M Lio, Yinghong Gao, et al.
Pageof 2